| 1 | forced | 2,534 |
| 2 | quality-adjusted | 1,207 |
| 3 | glycated | 943 |
| 4 | glycosylated | 848 |
| 5 | disability-adjusted | 48 |
| 6 | /forced | 26 |
| 7 | fev1/forced | 11 |
| 8 | pyridoxalated | 8 |
| 9 | heteromorphic | 7 |
| 10 | dollars/quality-adjusted | 5 |
| 11 | corning | 4 |
| 12 | cost/quality-adjusted | 4 |
| 13 | enzo | 4 |
| 14 | glycosilated | 4 |
| 15 | in-bed | 4 |
| 16 | life-adjusted | 4 |
| 17 | μmol/min/g | 4 |
| 18 | carpe | 3 |
| 19 | meta-analysis.forced | 3 |
| 20 | nightguard | 3 |
| 21 | peep+low | 3 |
| 22 | pustulata | 3 |
| 23 | 1s/forced | 2 |
| 24 | 4-mile | 2 |
| 25 | carious-exposed | 2 |
| 26 | expiration/forced | 2 |
| 27 | four-stair | 2 |
| 28 | glycosolated | 2 |
| 29 | high-peak | 2 |
| 30 | juxtaluminal | 2 |
| 31 | natren | 2 |
| 32 | nicrophorus | 2 |
| 33 | not.positive | 2 |
| 34 | plateau-shaped | 2 |
| 35 | p⊂et | 2 |
| 36 | work-private | 2 |
| 37 | £20,000/quality-adjusted | 2 |
| 38 | 'freiburg | 1 |
| 39 | +501 | 1 |
| 40 | 0,117 | 1 |
| 41 | 0.000024 | 1 |
| 42 | 0.00423 | 1 |
| 43 | 0.00809 | 1 |
| 44 | 0.0316 | 1 |
| 45 | 0.1796 | 1 |
| 46 | 0.1999 | 1 |
| 47 | 0.45mol/l | 1 |
| 48 | 0·103 | 1 |
| 49 | 1-second/forced | 1 |
| 50 | 1.5-km | 1 |
| 51 | 10-meters | 1 |
| 52 | 10-stair | 1 |
| 53 | 10-steps | 1 |
| 54 | 13,400 | 1 |
| 55 | 131,700 | 1 |
| 56 | 133,900 | 1 |
| 57 | 14,505 | 1 |
| 58 | 1963/10,000 | 1 |
| 59 | 2-host | 1 |
| 60 | 20,000pounds | 1 |
| 61 | 2359/10,000 | 1 |
| 62 | 27,096€/quality-adjusted | 1 |
| 63 | 304,765-724,195 | 1 |
| 64 | 50-step | 1 |
| 65 | 537,399 | 1 |
| 66 | 65.8±16.8ml/min/per | 1 |
| 67 | =10-year | 1 |
| 68 | a1-c | 1 |
| 69 | acid/optibond | 1 |
| 70 | atrial-pulmonary | 1 |
| 71 | attainment-glycated | 1 |
| 72 | awt-aerobic | 1 |
| 73 | campanulotes | 1 |
| 74 | certificate-based | 1 |
| 75 | chikusan | 1 |
| 76 | child/infant | 1 |
| 77 | cs-saturated | 1 |
| 78 | cynmeth | 1 |
| 79 | d-aminoacyl-trna | 1 |
| 80 | death/100 | 1 |
| 81 | diabeteszentrum | 1 |
| 82 | dignified | 1 |
| 83 | early-/late-wave | 1 |
| 84 | echocardiograph-determined | 1 |
| 85 | euro100,000/quality-adjusted | 1 |
| 86 | euros/quality-adjusted | 1 |
| 87 | extracorpuscular | 1 |
| 88 | fev1/inspiratory | 1 |
| 89 | fine-pitch | 1 |
| 90 | fingertip- | 1 |
| 91 | flow/total | 1 |
| 92 | flows/peak | 1 |
| 93 | glomerulus/renal | 1 |
| 94 | glucated | 1 |
| 95 | glycoated | 1 |
| 96 | glycocylated | 1 |
| 97 | glycoslyated | 1 |
| 98 | in-check | 1 |
| 99 | inclusion.glycosylated | 1 |
| 100 | inter-temporal | 1 |
| 101 | longer-distance | 1 |
| 102 | maximum | 1 |
| 103 | medium-cost | 1 |
| 104 | middle-speed | 1 |
| 105 | multi-jurisdictional | 1 |
| 106 | nasal-peak | 1 |
| 107 | non-practicers | 1 |
| 108 | normal-velocity | 1 |
| 109 | one-second/forced | 1 |
| 110 | open-boats | 1 |
| 111 | orthomol | 1 |
| 112 | parasite/pathogen | 1 |
| 113 | peak-to-mean | 1 |
| 114 | personal/social | 1 |
| 115 | piramal | 1 |
| 116 | plesiadapid | 1 |
| 117 | positive-end | 1 |
| 118 | post-embryonic | 1 |
| 119 | preoperative-forced | 1 |
| 120 | proterochampsian | 1 |
| 121 | pyridoxylated | 1 |
| 122 | quality-ajusted | 1 |
| 123 | quality-of | 1 |
| 124 | qualityadjusted | 1 |
| 125 | saccharogenic | 1 |
| 126 | satellite-lab | 1 |
| 127 | semi-diurnal | 1 |
| 128 | single-canaled | 1 |
| 129 | spirometry-forced | 1 |
| 130 | volume/forced | 1 |
| 131 | volume/peak | 1 |
| 132 | work–home | 1 |
| 133 | yen/quality-adjusted | 1 |
| 134 | ~bullet~brisk | 1 |
| 135 | €3,517/ | 1 |
| 136 | €30,000/quality-adjusted | 1 |
| 137 | €32,652/quality-adjusted | 1 |
| 138 | €40,980/quality-adjusted | 1 |
| 1 | 'freiburg | 1 |
| 2 | +501 | 1 |
| 3 | /forced | 26 |
| 4 | 0,117 | 1 |
| 5 | 0.000024 | 1 |
| 6 | 0.00423 | 1 |
| 7 | 0.00809 | 1 |
| 8 | 0.0316 | 1 |
| 9 | 0.1796 | 1 |
| 10 | 0.1999 | 1 |
| 11 | 0.45mol/l | 1 |
| 12 | 0·103 | 1 |
| 13 | 1-second/forced | 1 |
| 14 | 1.5-km | 1 |
| 15 | 10-meters | 1 |
| 16 | 10-stair | 1 |
| 17 | 10-steps | 1 |
| 18 | 13,400 | 1 |
| 19 | 131,700 | 1 |
| 20 | 133,900 | 1 |
| 21 | 14,505 | 1 |
| 22 | 1963/10,000 | 1 |
| 23 | 1s/forced | 2 |
| 24 | 2-host | 1 |
| 25 | 20,000pounds | 1 |
| 26 | 2359/10,000 | 1 |
| 27 | 27,096€/quality-adjusted | 1 |
| 28 | 304,765-724,195 | 1 |
| 29 | 4-mile | 2 |
| 30 | 50-step | 1 |
| 31 | 537,399 | 1 |
| 32 | 65.8±16.8ml/min/per | 1 |
| 33 | =10-year | 1 |
| 34 | a1-c | 1 |
| 35 | acid/optibond | 1 |
| 36 | atrial-pulmonary | 1 |
| 37 | attainment-glycated | 1 |
| 38 | awt-aerobic | 1 |
| 39 | campanulotes | 1 |
| 40 | carious-exposed | 2 |
| 41 | carpe | 3 |
| 42 | certificate-based | 1 |
| 43 | chikusan | 1 |
| 44 | child/infant | 1 |
| 45 | corning | 4 |
| 46 | cost/quality-adjusted | 4 |
| 47 | cs-saturated | 1 |
| 48 | cynmeth | 1 |
| 49 | d-aminoacyl-trna | 1 |
| 50 | death/100 | 1 |
| 51 | diabeteszentrum | 1 |
| 52 | dignified | 1 |
| 53 | disability-adjusted | 48 |
| 54 | dollars/quality-adjusted | 5 |
| 55 | early-/late-wave | 1 |
| 56 | echocardiograph-determined | 1 |
| 57 | enzo | 4 |
| 58 | euro100,000/quality-adjusted | 1 |
| 59 | euros/quality-adjusted | 1 |
| 60 | expiration/forced | 2 |
| 61 | extracorpuscular | 1 |
| 62 | fev1/forced | 11 |
| 63 | fev1/inspiratory | 1 |
| 64 | fine-pitch | 1 |
| 65 | fingertip- | 1 |
| 66 | flow/total | 1 |
| 67 | flows/peak | 1 |
| 68 | forced | 2,534 |
| 69 | four-stair | 2 |
| 70 | glomerulus/renal | 1 |
| 71 | glucated | 1 |
| 72 | glycated | 943 |
| 73 | glycoated | 1 |
| 74 | glycocylated | 1 |
| 75 | glycosilated | 4 |
| 76 | glycoslyated | 1 |
| 77 | glycosolated | 2 |
| 78 | glycosylated | 848 |
| 79 | heteromorphic | 7 |
| 80 | high-peak | 2 |
| 81 | in-bed | 4 |
| 82 | in-check | 1 |
| 83 | inclusion.glycosylated | 1 |
| 84 | inter-temporal | 1 |
| 85 | juxtaluminal | 2 |
| 86 | life-adjusted | 4 |
| 87 | longer-distance | 1 |
| 88 | maximum | 1 |
| 89 | medium-cost | 1 |
| 90 | meta-analysis.forced | 3 |
| 91 | middle-speed | 1 |
| 92 | multi-jurisdictional | 1 |
| 93 | nasal-peak | 1 |
| 94 | natren | 2 |
| 95 | nicrophorus | 2 |
| 96 | nightguard | 3 |
| 97 | non-practicers | 1 |
| 98 | normal-velocity | 1 |
| 99 | not.positive | 2 |
| 100 | one-second/forced | 1 |
| 101 | open-boats | 1 |
| 102 | orthomol | 1 |
| 103 | parasite/pathogen | 1 |
| 104 | peak-to-mean | 1 |
| 105 | peep+low | 3 |
| 106 | personal/social | 1 |
| 107 | piramal | 1 |
| 108 | plateau-shaped | 2 |
| 109 | plesiadapid | 1 |
| 110 | positive-end | 1 |
| 111 | post-embryonic | 1 |
| 112 | preoperative-forced | 1 |
| 113 | proterochampsian | 1 |
| 114 | pustulata | 3 |
| 115 | pyridoxalated | 8 |
| 116 | pyridoxylated | 1 |
| 117 | p⊂et | 2 |
| 118 | quality-adjusted | 1,207 |
| 119 | quality-ajusted | 1 |
| 120 | quality-of | 1 |
| 121 | qualityadjusted | 1 |
| 122 | saccharogenic | 1 |
| 123 | satellite-lab | 1 |
| 124 | semi-diurnal | 1 |
| 125 | single-canaled | 1 |
| 126 | spirometry-forced | 1 |
| 127 | volume/forced | 1 |
| 128 | volume/peak | 1 |
| 129 | work-private | 2 |
| 130 | work–home | 1 |
| 131 | yen/quality-adjusted | 1 |
| 132 | ~bullet~brisk | 1 |
| 133 | £20,000/quality-adjusted | 2 |
| 134 | μmol/min/g | 4 |
| 135 | €3,517/ | 1 |
| 136 | €30,000/quality-adjusted | 1 |
| 137 | €32,652/quality-adjusted | 1 |
| 138 | €40,980/quality-adjusted | 1 |
| 1 | fingertip- | 1 |
| 2 | €3,517/ | 1 |
| 3 | 1963/10,000 | 1 |
| 4 | 2359/10,000 | 1 |
| 5 | death/100 | 1 |
| 6 | 13,400 | 1 |
| 7 | 131,700 | 1 |
| 8 | 133,900 | 1 |
| 9 | +501 | 1 |
| 10 | 0·103 | 1 |
| 11 | 0.00423 | 1 |
| 12 | 0.000024 | 1 |
| 13 | 14,505 | 1 |
| 14 | 304,765-724,195 | 1 |
| 15 | 0.0316 | 1 |
| 16 | 0.1796 | 1 |
| 17 | 0,117 | 1 |
| 18 | 0.00809 | 1 |
| 19 | 537,399 | 1 |
| 20 | 0.1999 | 1 |
| 21 | d-aminoacyl-trna | 1 |
| 22 | pustulata | 3 |
| 23 | satellite-lab | 1 |
| 24 | a1-c | 1 |
| 25 | awt-aerobic | 1 |
| 26 | heteromorphic | 7 |
| 27 | saccharogenic | 1 |
| 28 | post-embryonic | 1 |
| 29 | in-bed | 4 |
| 30 | forced | 2,534 |
| 31 | preoperative-forced | 1 |
| 32 | spirometry-forced | 1 |
| 33 | meta-analysis.forced | 3 |
| 34 | /forced | 26 |
| 35 | fev1/forced | 11 |
| 36 | 1-second/forced | 1 |
| 37 | one-second/forced | 1 |
| 38 | volume/forced | 1 |
| 39 | expiration/forced | 2 |
| 40 | 1s/forced | 2 |
| 41 | middle-speed | 1 |
| 42 | dignified | 1 |
| 43 | single-canaled | 1 |
| 44 | echocardiograph-determined | 1 |
| 45 | plateau-shaped | 2 |
| 46 | certificate-based | 1 |
| 47 | carious-exposed | 2 |
| 48 | glucated | 1 |
| 49 | glycated | 943 |
| 50 | attainment-glycated | 1 |
| 51 | pyridoxalated | 8 |
| 52 | glycosilated | 4 |
| 53 | glycosolated | 2 |
| 54 | glycocylated | 1 |
| 55 | glycosylated | 848 |
| 56 | inclusion.glycosylated | 1 |
| 57 | pyridoxylated | 1 |
| 58 | glycoated | 1 |
| 59 | cs-saturated | 1 |
| 60 | glycoslyated | 1 |
| 61 | quality-ajusted | 1 |
| 62 | life-adjusted | 4 |
| 63 | quality-adjusted | 1,207 |
| 64 | euro100,000/quality-adjusted | 1 |
| 65 | £20,000/quality-adjusted | 2 |
| 66 | €30,000/quality-adjusted | 1 |
| 67 | €40,980/quality-adjusted | 1 |
| 68 | €32,652/quality-adjusted | 1 |
| 69 | yen/quality-adjusted | 1 |
| 70 | euros/quality-adjusted | 1 |
| 71 | dollars/quality-adjusted | 5 |
| 72 | cost/quality-adjusted | 4 |
| 73 | 27,096€/quality-adjusted | 1 |
| 74 | disability-adjusted | 48 |
| 75 | qualityadjusted | 1 |
| 76 | plesiadapid | 1 |
| 77 | positive-end | 1 |
| 78 | acid/optibond | 1 |
| 79 | nightguard | 3 |
| 80 | longer-distance | 1 |
| 81 | 4-mile | 2 |
| 82 | work–home | 1 |
| 83 | carpe | 3 |
| 84 | work-private | 2 |
| 85 | early-/late-wave | 1 |
| 86 | not.positive | 2 |
| 87 | quality-of | 1 |
| 88 | μmol/min/g | 4 |
| 89 | corning | 4 |
| 90 | 'freiburg | 1 |
| 91 | fine-pitch | 1 |
| 92 | cynmeth | 1 |
| 93 | high-peak | 2 |
| 94 | nasal-peak | 1 |
| 95 | volume/peak | 1 |
| 96 | flows/peak | 1 |
| 97 | in-check | 1 |
| 98 | ~bullet~brisk | 1 |
| 99 | 0.45mol/l | 1 |
| 100 | personal/social | 1 |
| 101 | piramal | 1 |
| 102 | glomerulus/renal | 1 |
| 103 | juxtaluminal | 2 |
| 104 | multi-jurisdictional | 1 |
| 105 | semi-diurnal | 1 |
| 106 | inter-temporal | 1 |
| 107 | flow/total | 1 |
| 108 | orthomol | 1 |
| 109 | 1.5-km | 1 |
| 110 | maximum | 1 |
| 111 | diabeteszentrum | 1 |
| 112 | peak-to-mean | 1 |
| 113 | proterochampsian | 1 |
| 114 | chikusan | 1 |
| 115 | parasite/pathogen | 1 |
| 116 | natren | 2 |
| 117 | enzo | 4 |
| 118 | 50-step | 1 |
| 119 | =10-year | 1 |
| 120 | extracorpuscular | 1 |
| 121 | 65.8±16.8ml/min/per | 1 |
| 122 | 10-stair | 1 |
| 123 | four-stair | 2 |
| 124 | 20,000pounds | 1 |
| 125 | campanulotes | 1 |
| 126 | 10-steps | 1 |
| 127 | non-practicers | 1 |
| 128 | 10-meters | 1 |
| 129 | open-boats | 1 |
| 130 | nicrophorus | 2 |
| 131 | p⊂et | 2 |
| 132 | child/infant | 1 |
| 133 | medium-cost | 1 |
| 134 | 2-host | 1 |
| 135 | peep+low | 3 |
| 136 | atrial-pulmonary | 1 |
| 137 | fev1/inspiratory | 1 |
| 138 | normal-velocity | 1 |